Skip to the page

Data / Form D filings / HbA1c, LP

HbA1c, LP: Form D filing

HbA1c, LP, a company in Los Angeles, CA, filed a Form D with the SEC in 2025. The latest, on November 5, 2025, reports $4.8 million sold of a $11.5 million offering to 15 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
5042 WILSHIRE BLVD. #26878, Los Angeles, CA, 90036
Phone
(310) 415-9251
Industry
Other
Entity type
Limited Partnership
Incorporated in
Delaware
Year incorporated
2025
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b), Investment Company Act section 3(c), section 3(c)(1)
SEC identifier (CIK)
2094213

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Nov 5, 2025New notice$11,500,000$4,800,000$6,700,00015Oct 20, 2025sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Jason JohnsonExecutive Officer
Bryan JohnsonExecutive Officer

Other companies in California that filed recently

Every Form D from the week of Nov 3, 2025 · All recent filings in California · All recent Other filings

Read from SEC EDGAR. Amount sold is what HbA1c, LP reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.